David Lee
Overview
Explore the profile of David Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
515
Citations
9046
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Piraner D, Abedi M, Duran Gonzalez M, Chazin-Gray A, Lin A, Zhu I, et al.
Nature
. 2024 Nov;
638(8051):805-813.
PMID: 39542025
Despite recent advances in mammalian synthetic biology, there remains a lack of modular synthetic receptors that can robustly respond to soluble ligands and, in turn, activate bespoke cellular functions. Such...
12.
Guevarra Almonte K, Mumford G, Smith-Mumford P, Lee D, Pavlakis M, Hoenig M, et al.
Am J Kidney Dis
. 2024 Nov;
85(3):A13-A15.
PMID: 39520452
No abstract available.
13.
Wang F, Nguyen P, Lee D, Taysi B, Lefebvre dHellencourt F, Spinardi J, et al.
J Glob Health
. 2024 Nov;
14:05032.
PMID: 39513295
Background: Antivirals are effective in reducing hospitalisation and death in mild-to-moderate coronavirus 2019 (COVID-19) patients. We estimated the antiviral uptake of nirmatrelvir/ritonavir and molnupiravir in adult patients with a syndrome...
14.
Soe N, Latt P, King A, Lee D, Phillips T, Fairley C, et al.
Patient
. 2024 Nov;
18(2):131-143.
PMID: 39485672
Background: One of the World Health Organization (WHO) recommendations to achieve its global targets for sexually transmitted infections (STIs) is the increased use of digital technologies. Melbourne Sexual Health Centre...
15.
Lee D, Shen A, Shah M, Garbuzenko O, Minko T
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39408684
Our study took an innovative approach by evaluating, in vivo, the efficacy of intranasal (IN) administration of liposomal formulations of donepezil, memantine, and beta-site amyloid precursor protein-cleaving enzyme (BACE-1) siRNA,...
16.
Zuccaro J, Lee D, Kelly C, Chakera H, Turner E, Gus E, et al.
J Burn Care Res
. 2024 Sep;
46(1):22-27.
PMID: 39329469
Small burn injuries are extremely prevalent in the pediatric population and continue to pose a challenge for clinicians. Despite their high incidence, a standardized algorithm for treating small burns does...
17.
Soe N, Yu Z, Latt P, Lee D, Samra R, Ge Z, et al.
J Med Internet Res
. 2024 Sep;
26:e52490.
PMID: 39269753
Background: The 2022 global outbreak of mpox has significantly impacted health facilities, and necessitated additional infection prevention and control measures and alterations to clinic processes. Early identification of suspected mpox...
18.
Kuruvilla J, Rushton C, Villa D, Aslam M, Prica A, Abdel Samad N, et al.
Br J Haematol
. 2024 Sep;
205(5):2067-2071.
PMID: 39267295
In the LY.17 randomized phase II clinical trial, adults with relapsed and refractory diffuse large B-cell lymphoma treated with ibrutinib-R-GDP (IR-GDP) for up to three cycles had more documented bacterial...
19.
Ehsanian R, Malone D, Hambraeus J, Monteiro P, Hodde M, Lee D, et al.
Interv Pain Med
. 2024 Sep;
1(1):100010.
PMID: 39238811
Objective: Apply established principles of evidence-based medicine to the interpretation of the cost-effectiveness analysis related to the MINT Randomized Clinical Trials (RCTs). Design: Editorial. Methods: Spine Intervention Society's guidelines for...
20.
Lee D, Shen A, Garbuzenko O, Minko T
AAPS J
. 2024 Sep;
26(5):99.
PMID: 39231845
β-site amyloid precursor protein cleaving enzyme (BACE1) represents a key target for Alzheimer's disease (AD) therapy because it is essential for producing the toxic amyloid β (Aβ) peptide that plays...